Biomarker activity and chronic heart failure in adult patients with congenital heart disease.

Biomarker activity and chronic heart failure in adult patients with congenital heart disease. - BioCon

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44822

Enrollment

602

Registered

2010-08-10

Start date

2011-05-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients to be included must meet the following criteria: 1. Men and women, aged 18 years or older, capable of understanding and signing informed consent. 2. Patients is known with a congenital heart disease. Cardiac diagnoses are atrial septal defect, ventricular septal defect, pulmonal stenoses, Tetralogy of Fallot, Transposition of the great arteries, eisenmenger syndrome, aortic pathology and Fontan circulation.

Exclusion criteria

Exclusion criteria: Patients living abroad or who were not Dutch speaking.

Design outcomes

Primary

Measure	Time frame
Cardiovascular death or complications as heartfailure, hospitalization, reoperation, arrhythmias and thormboembolic events.	—

Countries

Netherlands

Outcome results